This report focuses on the global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Edema Therapeutics development in United States, Europe and China. Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics. In 2017, the global Macular Edema Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Allergan Novartis Roche Regeneron Pharmaceuticals Pfizer Bayer Boehringer Ingelheim Bausch & Lomb Aciont ActiveSite Pharmaceuticals Adverum Biotechnologies Aerpio Therapeutics Ampio Pharmaceuticals Araim Pharmaceuticals Astellas Pharma Market segment by Type, the product can be split into Laser Treatment Anti-VEGF Injection Anti-Inflammatory Treatment Vitrectomy Market segment by Application, split into Cystoid Macular Edema (CME) Diabetic Macular Edema(DME) Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Macular Edema Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Macular Edema Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type (2013-2025) 1.4.2 Laser Treatment 1.4.3 Anti-VEGF Injection 1.4.4 Anti-Inflammatory Treatment 1.4.5 Vitrectomy 1.5 Market by Applic
